BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
65.68
+0.17 (0.26%)
At close: Sep 11, 2026, 4:00 PM EDT
65.80
+0.12 (0.18%)
After-hours: Sep 11, 2026, 7:30 PM EDT
BioMarin Pharmaceutical Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $80 | Buy | Maintains | $80 | +21.80% | Sep 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Hold Reiterates $60 | Hold | Reiterates | $60 | -8.65% | Sep 10, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $70 | Hold | Maintains | $70 | +6.58% | Sep 1, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $85 → $86 | Buy | Maintains | $85 → $86 | +30.94% | Sep 1, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $114 | Buy | Maintains | $114 | +73.57% | Sep 1, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $124 | Buy | Reiterates | $124 | +88.79% | Sep 1, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $88 → $90 | Buy | Maintains | $88 → $90 | +37.03% | Sep 1, 2026 |
| Jefferies | Jefferies | Buy Maintains $104 → $105 | Buy | Maintains | $104 → $105 | +59.87% | Aug 31, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.